LOGO
LOGO

quick facts

  • Apollo Funds To Acquire About 13% Minority Interest In McKesson's Medical-Surgical Solutions April 20, 2026 08:36 ET

    McKesson Corporation (MCK), a healthcare service provider, said on Monday that it has inked a deal with Apollo Funds to sell a minority ownership interest in Medical-Surgical Solutions, or MMS, business. "This transaction represents a meaningful milestone as McKesson executes its separation strategy...

  • Domino's Pizza Now Offers 50% Discount On All Menu-Priced Pizzas Ordered Online April 20, 2026 08:27 ET

    Domino's Pizza, Inc. (DPZ), Monday announced that customers can now get 50 percent discount on all menu-priced pizzas ordered online from April 20 to 26. "From the first pick to the final round, Domino's is here with a deal that makes draft-day gatherings even better. Whether you're feeding a full...

  • Ennis Q4 Net Earnings Slip Despite Revenue Gain April 20, 2026 08:07 ET

    Ennis, Inc., (EBF) a U.S. based supplier of business products, Monday reported lower earnings for its fourth quarter in spite of higher revenues For the fourth quarter, Net earnings came in at $8.84 million compared to $9.02 million last year. The company reported a one time other expense of $4.2...

  • Surf Air Mobility Revises Annual Adj. EBITDA Loss Outlook On Reduced Costs; Backs Revenue Guidance April 20, 2026 08:01 ET

    Surf Air Mobility Inc.(SRFM), an American aviation company, on Monday revised its adjusted EBITDA loss guidance and reaffirmed its revenue outlook for fiscal 2026. Deanna White, CEO of Surf Air Mobility, said:"SurfOS and our work with Palantir is driving measurable efficiency and cost savings. Improving...

  • Pasithea Wins FDA Rare Pediatric Disease Status For PAS-004 To Treat Neurofibromatosis Type 1 April 20, 2026 07:56 ET

    Pasithea Therapeutics Corp. (KTTA) on Monday said the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation to PAS-004 for the treatment of Neurofibromatosis Type 1 (NF1), a rare genetic disorder. The designation makes the program eligible for a Priority Review Voucher if...

  • Astellas, Pfizer Say FDA Grants Priority Review To SBLA For PADCEV Plus Keytruda April 20, 2026 07:42 ET

    Astellas Pharma Inc. (ALPMY) and Pfizer Inc. (PFE) on Monday said the U.S. Food and Drug Administration has granted Priority Review for a supplemental Biologics License Application for perioperative PADCEV in combination with Keytruda as a treatment for patients with Muscle-Invasive Bladder Cancer (MIBC). The...

  • Biogen To Acquire TJ Bio's Rights To Felzartamab In The Greater China Region April 20, 2026 07:41 ET

    Biogen Inc. (BIIB) and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bio's exclusive rights to felzartamab in the Greater China Region. Biogen now owns exclusive worldwide rights to felzartamab, which is currently being evaluated in global Phase 3 clinical...

  • ANI Pharmaceuticals Launches Pimozide Tablets 1 Mg And 2 Mg April 20, 2026 07:40 ET

    ANI Pharmaceuticals, Inc. (ANIP), Monday announced the launch of Pimozide Tablets 1 mg and 2 mg, which is the generic version of the reference listed drug (RLD) Orap. Notably, U.S. annual sales for Pimozide Tablets total approximately $3.1 million, as per the February 2026 moving annual total IQVIA...

  • Broadridge Financial Solutions Announces Minority Investment In CENTRL April 20, 2026 07:30 ET

    Broadridge Financial Solutions (BR) announced a strategic partnership and minority investment in CENTRL, a provider of AI-powered due diligence solutions for financial institutions. Broadridge will integrate CENTRL's AI-powered workflow and automation capabilities across solutions serving asset managers,...

  • Sagimet Names Andreas Grauer CMO April 20, 2026 07:23 ET

    Sagimet Biosciences Inc. (SGMT), on Monday announced the appointment of Andreas Grauer as Chief Medical Officer, effective April 20. Eduardo Bruno Martins has retired as CMO and will continue to support the company as an external scientific advisor. Andreas Grauer brings more than two decades of...

  • Agnico Eagle Mines To Acquire Aurion April 20, 2026 06:48 ET

    Aurion Resources (AU.V) has entered into a definitive arrangement agreement pursuant to which Agnico Eagle Mines Limited (AEM.TO, AEM) has agreed to acquire all of the issued and outstanding common shares of Aurion, other than the Aurion shares currently held by Agnico Eagle, by way of a statutory plan...

  • USA Rare Earth To Acquire Serra Verde In $2.8 Bln Deal April 20, 2026 06:38 ET

    USA Rare Earth Inc. (USAR) on Monday said it has agreed to acquire Serra Verde Group, owner of the Pela Ema rare earth mine and processing plant in Brazil, in a deal valued at about $2.8 billion. The consideration includes $300 million in cash and about 126.8 million newly issued USAR shares. The...

  • Cleveland-Cliffs Posts Narrower Loss In Q1 April 20, 2026 06:29 ET

    Cleveland-Cliffs Inc. (CLF) reported a first quarter GAAP net loss of $229 million, or $0.42 per diluted share, compared to a net loss of $486 million, or $1.01 per diluted share, a year ago. Adjusted net loss was $0.40 per diluted share compared to a loss of $0.93 per diluted share. Adjusted EBITDA...

  • Howard Hughes Names Marc Grandisson To Board April 20, 2026 06:28 ET

    Howard Hughes Holdings Inc. (HHH), on Monday announced the appointment of Marc Grandisson to its Board of Directors, effective May 7. Marc Grandisson previously served as Chief Executive Officer of Arch Capital Group Ltd. (ACGLO, ACGL) from 2018 until his retirement in 2024 and was part of the company's...

  • Outcrop Silver CEO Ian Harris Steps Down; Rob Bruggeman Appointed Successor April 20, 2026 06:09 ET

    Outcrop Silver & Gold Corp. (OCGSF, OCG.TO), on Monday announced that Ian Harris has stepped down as Chief Executive Officer, with Rob Bruggeman appointed as CEO and Director, effective immediately. Ian Harris will transition to the role of Chairman of the Board, while Jay Sujir will remain on the...

Global Economics Weekly Update: April 13 – April 17, 2026

April 17, 2026 15:29 ET
The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.